However, this drug isn’t being sold on a competitive market. Because it is a specialized drug, there are very few treatment alternatives created, and none of them are equivalent to Daraprim. This means that the company is able to charge much higher prices, because they have a unique and superior product. Consumers are forced to pay these higher
However, this drug isn’t being sold on a competitive market. Because it is a specialized drug, there are very few treatment alternatives created, and none of them are equivalent to Daraprim. This means that the company is able to charge much higher prices, because they have a unique and superior product. Consumers are forced to pay these higher